Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER).

Cho EA, Moloney FJ, Cai H, Au-Yeung A, China C, Scolyer RA, Yosufi B, Raftery MJ, Deng JZ, Morton SW, Hammond PT, Arkenau HT, Damian DL, Francis DJ, Chesterman CN, Barnetson RS, Halliday GM, Khachigian LM.

Lancet. 2013 May 25;381(9880):1835-43. doi: 10.1016/S0140-6736(12)62166-7. Epub 2013 May 7.

2.

Destroying c-jun Messenger: new insights into biological mechanisms of DNAzyme function.

Khachigian LM, Cai H, Moloney FJ, Parish CR, Chong BH, Stocker R, Barnetson RS, Halliday GM.

Oncotarget. 2012 Jun;3(6):594-5.

3.

DNAzyme targeting c-jun suppresses skin cancer growth.

Cai H, Santiago FS, Prado-Lourenco L, Wang B, Patrikakis M, Davenport MP, Maghzal GJ, Stocker R, Parish CR, Chong BH, Lieschke GJ, Wong TW, Chesterman CN, Francis DJ, Moloney FJ, Barnetson RS, Halliday GM, Khachigian LM.

Sci Transl Med. 2012 Jun 20;4(139):139ra82. doi: 10.1126/scitranslmed.3003960.

4.

BRM and BRG1 subunits of the SWI/SNF chromatin remodelling complex are downregulated upon progression of benign skin lesions into invasive tumours.

Bock VL, Lyons JG, Huang XX, Jones AM, McDonald LA, Scolyer RA, Moloney FJ, Barnetson RS, Halliday GM.

Br J Dermatol. 2011 Jun;164(6):1221-7. doi: 10.1111/j.1365-2133.2011.10267.x. Epub 2011 May 13.

PMID:
21564052
5.

Western lifestyle and increased prevalence of atopic diseases: an example from a small papua new guinean island.

Herbert OCh, Barnetson RS, Weninger W, Krämer U, Behrendt H, Ring J.

World Allergy Organ J. 2009 Jul;2(7):130-7. doi: 10.1097/WOX.0b013e3181accf27.

6.

UV radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide.

Damian DL, Patterson CR, Stapelberg M, Park J, Barnetson RS, Halliday GM.

J Invest Dermatol. 2008 Feb;128(2):447-54. Epub 2007 Sep 20.

7.

Treatment of refractory chromomycosis by isolated limb infusion with melphalan and actinomycin D.

Damian DL, Barnetson RS, Thompson JF.

J Cutan Med Surg. 2006 Jan-Feb;10(1):48-51.

PMID:
17241574
8.

Topical capsaicin reduces ultraviolet radiation-induced suppression of Mantoux reactions in humans.

Howes RA, Halliday GM, Barnetson RS, Friedmann AC, Damian DL.

J Dermatol Sci. 2006 Nov;44(2):113-5. Epub 2006 Sep 14. No abstract available.

PMID:
16973333
9.

Melanin differentially protects from the initiation and progression of threshold UV-induced erythema depending on UV waveband.

Phan TA, Halliday GM, Barnetson RS, Damian DL.

Photodermatol Photoimmunol Photomed. 2006 Aug;22(4):174-80.

PMID:
16869864
10.

Squamous cell carcinoma growth in mice and in culture is regulated by c-Jun and its control of matrix metalloproteinase-2 and -9 expression.

Zhang G, Luo X, Sumithran E, Pua VS, Barnetson RS, Halliday GM, Khachigian LM.

Oncogene. 2006 Nov 23;25(55):7260-6. Epub 2006 Jun 19.

PMID:
16785994
11.

[Nle4-D-Phe7]-alpha-melanocyte-stimulating hormone significantly increased pigmentation and decreased UV damage in fair-skinned Caucasian volunteers.

Barnetson RS, Ooi TK, Zhuang L, Halliday GM, Reid CM, Walker PC, Humphrey SM, Kleinig MJ.

J Invest Dermatol. 2006 Aug;126(8):1869-78. Epub 2006 Jun 8.

12.

Recent developments in the treatment of adult atopic dermatitis.

Pua VS, Barnetson RS.

Australas J Dermatol. 2006 May;47(2):84-9. Review.

PMID:
16637800
13.

Pravastatin-induced lichenoid drug eruption.

Pua VS, Scolyer RA, Barnetson RS.

Australas J Dermatol. 2006 Feb;47(1):57-9. Review.

PMID:
16405486
14.

Imiquimod-induced regression of actinic keratosis is associated with infiltration by T lymphocytes and dendritic cells: a randomized controlled trial.

Ooi T, Barnetson RS, Zhuang L, McKane S, Lee JH, Slade HB, Halliday GM.

Br J Dermatol. 2006 Jan;154(1):72-8.

PMID:
16403097
15.
16.

Spectral and dose dependence of ultraviolet radiation-induced immunosuppression.

Phan TA, Halliday GM, Barnetson RS, Damian DL.

Front Biosci. 2006 Jan 1;11:394-411. Review.

PMID:
16146741
17.

Psoriasis vulgaris flare during efalizumab therapy does not preclude future use: a case series.

Lowes MA, Turton JA, Krueger JG, Barnetson RS.

BMC Dermatol. 2005 Aug 18;5:9.

18.

Cyclobutane pyrimidine dimer formation is a molecular trigger for solar-simulated ultraviolet radiation-induced suppression of memory immunity in humans.

Kuchel JM, Barnetson RS, Halliday GM.

Photochem Photobiol Sci. 2005 Aug;4(8):577-82. Epub 2005 Jul 8.

PMID:
16052262
19.

Borderline lepromatous leprosy presenting as a single cutaneous plaque.

Armour KS, Scolyer RA, Barnetson RS.

Australas J Dermatol. 2005 Aug;46(3):181-3.

PMID:
16008652
20.

The topical isoflavonoid NV-07alpha reduces solar-simulated UV-induced suppression of Mantoux reactions in humans.

Friedmann AC, Halliday GM, Barnetson RS, Reeve VE, Walker C, Patterson CR, Damian DL.

Photochem Photobiol. 2004 Nov-Dec;80(3):416-21.

PMID:
15623323
21.
22.

UV-A fingerprint mutations in human skin cancer.

Halliday GM, Agar NS, Barnetson RS, Ananthaswamy HN, Jones AM.

Photochem Photobiol. 2005 Jan-Feb;81(1):3-8. Review.

PMID:
15335275
23.

The suppression of immunity by ultraviolet radiation: UVA, nitric oxide and DNA damage.

Halliday GM, Byrne SN, Kuchel JM, Poon TS, Barnetson RS.

Photochem Photobiol Sci. 2004 Aug;3(8):736-40. Epub 2004 Feb 3. Review.

PMID:
15295628
24.
25.

The basal layer in human squamous tumors harbors more UVA than UVB fingerprint mutations: a role for UVA in human skin carcinogenesis.

Agar NS, Halliday GM, Barnetson RS, Ananthaswamy HN, Wheeler M, Jones AM.

Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4954-9. Epub 2004 Mar 23.

26.

Objective measurement of minimal erythema and melanogenic doses using natural and solar-simulated light.

Poon TS, Kuchel JM, Badruddin A, Halliday GM, Barnetson RS, Iwaki H, Hatao M.

Photochem Photobiol. 2003 Oct;78(4):331-6.

PMID:
14626659
27.
28.

Mechanisms in cutaneous drug hypersensitivity reactions.

Friedmann PS, Lee MS, Friedmann AC, Barnetson RS.

Clin Exp Allergy. 2003 Jul;33(7):861-72. Review.

PMID:
12859440
30.

A novel technique for the examination of skin biopsies by laser capture microdissection.

Agar NS, Halliday GM, Barnetson RS, Jones AM.

J Cutan Pathol. 2003 Apr;30(4):265-70.

PMID:
12680959
31.

Treatment of dandruff with 5% tea tree oil shampoo.

Satchell AC, Saurajen A, Bell C, Barnetson RS.

J Am Acad Dermatol. 2002 Dec;47(6):852-5.

PMID:
12451368
32.

Sunlight and the Mantoux reaction.

Kuchel JM, Halliday GM, Barnetson RS.

Trop Doct. 2002 Oct;32(4):231-2. No abstract available.

PMID:
12405307
33.

The importance of using broad spectrum SPF 30+ sunscreens in tropical and subtropical climates.

Poon TS, Barnetson RS.

Photodermatol Photoimmunol Photomed. 2002 Aug;18(4):175-8.

PMID:
12390671
34.

Treatment of interdigital tinea pedis with 25% and 50% tea tree oil solution: a randomized, placebo-controlled, blinded study.

Satchell AC, Saurajen A, Bell C, Barnetson RS.

Australas J Dermatol. 2002 Aug;43(3):175-8.

PMID:
12121393
35.
36.

Childhood atopic eczema.

Barnetson RS, Rogers M.

BMJ. 2002 Jun 8;324(7350):1376-9. Review. No abstract available.

37.

Inflammation is associated with progression of actinic keratoses to squamous cell carcinomas in humans.

Berhane T, Halliday GM, Cooke B, Barnetson RS.

Br J Dermatol. 2002 May;146(5):810-5.

PMID:
12000377
38.

Multicentric reticulohistiocytosis presenting with a rash and arthralgia.

Hiramanek N, Kossard S, Barnetson RS.

Australas J Dermatol. 2002 May;43(2):136-9.

PMID:
11982572
39.
40.

Effects of low-dose ultraviolet radiation on in vivo human cutaneous recall responses.

Damian DL, Barnetson RS, Halliday GM.

Australas J Dermatol. 2001 Aug;42(3):161-7. Review.

PMID:
11488707
41.

Treatment of refractory hand warts by isolated limb infusion with melphalan and actinomycin D.

Damian DL, Barnetson RS, Rose BR, Bonenkamp JJ, Thompson JF.

Australas J Dermatol. 2001 May;42(2):106-9.

PMID:
11309032
42.

Staphylococcal septicaemia complicating treatment of atopic dermatitis with mycophenolate.

Satchell AC, Barnetson RS.

Br J Dermatol. 2000 Jul;143(1):202-3. No abstract available.

PMID:
10886168
43.

Cytokine profiles in spontaneously regressing basal cell carcinomas.

Wong DA, Bishop GA, Lowes MA, Cooke B, Barnetson RS, Halliday GM.

Br J Dermatol. 2000 Jul;143(1):91-8.

PMID:
10886141
44.

Topical retinoic acid enhances, and a dark tan protects, from subedemal solar-simulated photocarcinogenesis.

Halliday GM, Robertson BO, Barnetson RS.

J Invest Dermatol. 2000 May;114(5):923-7.

45.

Regression of melanoma, but not keratoacanthoma, is associated with increased HLA-B22 and decreased HLA-B27 and HLA-DR1.

Lowes MA, Dunckley H, Watson N, Crotty K, Cooke B, Barnetson RS, Halliday GM.

Melanoma Res. 1999 Dec;9(6):539-44.

PMID:
10661764
46.

Measurement of in vivo sunscreen immune protection factors in humans.

Damian DL, Barnetson RS, Halliday GM.

Photochem Photobiol. 1999 Dec;70(6):910-5.

PMID:
10628302
47.

Topical treatment of interdigital tinea pedis: terbinafine compared with clotrimazole.

Patel A, Brookman SD, Bullen MU, Marley J, Ellis DH, Williams T, Barnetson RS.

Australas J Dermatol. 1999 Nov;40(4):197-200.

PMID:
10570555
48.
49.
50.

UVA-induced immunosuppression.

Halliday GM, Bestak R, Yuen KS, Cavanagh LL, Barnetson RS.

Mutat Res. 1998 Nov 9;422(1):139-45.

PMID:
9920438

Supplemental Content

Loading ...
Support Center